Literature DB >> 16962651

Neurosteroids, neuroactive steroids, and symptoms of affective disorders.

Bernardo Dubrovsky1.   

Abstract

Neurosteroids (NS) are steroids synthesized by the brain. Neuroactive steroids (NAS) refers to steroids that, independent of their origin, are capable of modifying neural activities. NAS bind and modulate different types of membrane receptors. The gamma amino butyric acid (GABA) and sigma receptor complexes have been the most extensively studied. Oxidized ring A reduced pregnanes, tetrahydroprogesterone (THP), and tetrahydrodeoxycorticosterone (THDOC) bind to the progesterone intracellular receptor (PR), and in this way can also regulate gene expression. Animal experimentation showed that salient symptoms of depression, viz., anxiety, sleep disturbances, and memory and sexual dysfunctions, are modulated by NAS. In turn, psychotropic drugs modulate NS and NAS levels. NS levels as well as NAS plasma concentrations change in patients with depression syndromes, the levels return to normal baseline with recovery, but normalization is not necessary for successful therapy. Results from current studies on the evolution of nervous systems, including evolutionary developmental biology as well as anatomical and physiological findings, almost preclude a categorical classification of the psychiatric ailments the human brain succumbs to. The persistence in maintaining such essentialist classifications may help to explain why up to now the search for biological markers in psychiatry has been an unrewarding effort. It is proposed that it would be more fruitful to focus on relationships between NAS and symptoms of psychiatric disorders, rather than with typologically defined disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962651     DOI: 10.1016/j.pbb.2006.06.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  25 in total

1.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.

Authors:  James Hassell; Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

Review 2.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 3.  Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective.

Authors:  Michelle M Martel; Kelly Klump; Joel T Nigg; S Marc Breedlove; Cheryl L Sisk
Journal:  Horm Behav       Date:  2009-03-02       Impact factor: 3.587

Review 4.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

Review 5.  Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.

Authors:  Raymond Fertig; Jerry Shapiro; Wilma Bergfeld; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2016-09-23

6.  Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

Authors:  Roberto Frau; Giuliano Pillolla; Valentina Bini; Simone Tambaro; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2012-08-09       Impact factor: 4.905

Review 7.  Allopregnanolone as a mediator of affective switching in reproductive mood disorders.

Authors:  Crystal Edler Schiller; Peter J Schmidt; David R Rubinow
Journal:  Psychopharmacology (Berl)       Date:  2014-05-21       Impact factor: 4.530

8.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

9.  Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124.

Authors:  Lynda Uphouse; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

10.  Effect of low doses of progesterone in the expression of the GABA(A) receptor α4 subunit and procaspase-3 in the hypothalamus of female rats.

Authors:  Bruno D Arbo; Susie Andrade; Gabriela Osterkamp; Rosane Gomez; Maria Flávia M Ribeiro
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.